5/10
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
A Penn Medicine study finds that combining remdesivir or molnupiravir with the experimental drug brequinar blocked the replication of the virus that causes COVID-19 in lung cells.
Penn President Amy Gutmann’s record tenure of nearly 18 years is the University’s most transformative.
A new study from the School of Nursing suggests that stigma toward persons with substance abuse disorder may account for an under-assessment and management of pain, which leads to self-directed patient discharges.
The study, “Origins of the Opioid Crisis and its Enduring Impacts” examines the role of the 1996 introduction and marketing of OxyContin as a potential leading cause of the opioid crisis.
A new Penn study demonstrates that engineered macrophages, which can be targeted to tumors, may be a possible new immune-based treatment of some cancers.
An inequity in the rate of Black patients making it to their primary care appointment after a hospitalization was eliminated after telemedicine became widely used amid the COVID-19 pandemic.
Two new studies highlight the problem with aggregating diverse groups of people into a single category of “Asian American” when applied to cardiovascular disease and cancer diagnosis and outcomes.
Penn Medicine researchers have developed a new technique that uses complement inhibitor Factor I to prevent proteins from attacking treatment-carrying nanoparticles so they can better reach targets within the body.
Penn researchers find that using wearable devices, especially those on the wrist, and machine learning approaches could predict blood sugar control.
Making up for the genetic mutations of MLL4 in skin cells, one of the most commonly mutated genes across all of human cancers, may keep epithelial cancer from beginning and progressing
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →
Bruce Brod of the Perelman School of Medicine says that prolonged or overuse of topical steroids can cause rosacea, skin thinning, stretch marks, and an extreme and debilitating withdrawal.
FULL STORY →
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
The Hospital of the University of Pennsylvania has been named one of the most recommended acute-care facilities by patients in the Philadelphia area.
FULL STORY →